2019
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
TetraVax-DV
|
|
DENVax
|
|
CYD-TDV
|
|
Dengvaxia
|
Detailed explanation-1: -Indication: For the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9 through 16 years of age with laboratoryconfirmed previous dengue infection and living in endemic areas.
Detailed explanation-2: -Dengvaxia® is the world’s first vaccine approved to prevent dengue fever, which is a virus spread by mosquitoes primarily in tropical and sub-tropical areas. The Aedes aegypti mosquito spreads dengue in subtropical and tropical climates.
Detailed explanation-3: -The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.